1. Home
  2. PCRX vs CCNE Comparison

PCRX vs CCNE Comparison

Compare PCRX & CCNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.25

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo CNB Financial Corporation

CCNE

CNB Financial Corporation

HOLD

Current Price

$28.62

Market Cap

818.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
CCNE
Founded
2006
1865
Country
United States
United States
Employees
N/A
950
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
818.2M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
PCRX
CCNE
Price
$23.25
$28.62
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$37.20
$32.00
AVG Volume (30 Days)
677.8K
143.2K
Earning Date
05-07-2026
04-15-2026
Dividend Yield
N/A
2.52%
EPS Growth
107.44
N/A
EPS
0.16
N/A
Revenue
$541,533,000.00
N/A
Revenue This Year
$7.10
$23.21
Revenue Next Year
$9.15
$7.00
P/E Ratio
$145.31
$11.84
Revenue Growth
26.04
N/A
52 Week Low
$18.80
$19.32
52 Week High
$27.99
$30.84

Technical Indicators

Market Signals
Indicator
PCRX
CCNE
Relative Strength Index (RSI) 54.74 56.61
Support Level $22.57 $23.52
Resistance Level $23.91 $30.57
Average True Range (ATR) 0.86 0.69
MACD 0.05 0.14
Stochastic Oscillator 71.09 91.62

Price Performance

Historical Comparison
PCRX
CCNE

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About CCNE CNB Financial Corporation

CNB Financial Corp is a Pennsylvania-chartered bank. The bank is a full-service bank engaging in a full range of banking activities and services for individual, business, governmental and institutional customers. These activities and services principally include checking, savings, and time deposit accounts; real estate, commercial, industrial, residential and consumer loans; and a variety of other specialized financial services. Its Private Client Solutions division offers a full range of client services, including private banking and wealth and asset management. The banking segment derives its revenue through the operations as a full-service bank services, including trust and wealth management services, for individual, business, governmental, and institutional customers.

Share on Social Networks: